Physics Bucharest 2017

I-125 permanent prostate brachytherapy selection criteria

• Low or selected intermediate risk localised disease • Life expectancy > 10 years • Prostate volume < 50mls, if larger may need hormone treatment prior to brachytherapy to shrink prostate • Excluded - if significant obstructive urinary symptoms ( urine peak flow rate < 10mls per sec or large post-micturition residual volume ) as at high risk of catheterisation - previous Trans-Urethral Resection of Prostate ( TURP ) resulting in large prostate defect